• Aiuto
  • Sfoglia

    • ZINZANI, PIER LUIGI

    Rete di Collaborazioni Statistiche Email Alert RSS Feed

    Dipartimento:
    DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
    Ruolo:
    Docenti di ruolo di Ia fascia

    Pubblicazioni (Tutti)

    Risultati 1 - 20 di 365 (tempo di esecuzione: 0.002 secondi).

    TitoloAutore(i)AnnoPeriodicoEditoreTipo
    1Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome.Zinzani P.L.; Gandolfi L.; Stefoni V.; Fanti S.; Fina M.; Pellegrini C.; Montini G.C.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M.2010CLINICAL LYMPHOMA MYELOMA & LEUKEMIA1.01 Articolo in rivista
    2We are very happy and proud of this monographic issue of the Giornale Italiano di Dermatologia e Venereologia. Introduction.Bernengo MG;Santucci M;Zinzani PL2012GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA1.04 Replica / breve intervento (e simili)
    3VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.Fina M; Tani M; Stefoni V; Musuraca G; Marchi E; Pellegrini C; Alinari L; Derenzini E; Bacci F; Pileri S; Baccarani M; Zinzani PL.2007LEUKEMIA & LYMPHOMA1.01 Articolo in rivista
    4Vemurafenib mucosal side-effect.A. Pileri;M. Cricca;L. Gandolfi;C. Misciali;B. Casadei;P. L. Zinzani;A. Patrizi2016JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY1.01 Articolo in rivista
    5Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified.Piccaluga P.P.; Agostinelli C.; Gazzola A.; Sista M.T.; Righi S.; Bacci F.; Sabattini E.; Rossi M.; Mannu C.; Went P.; Zinzani P.L.; Pileri S.A.2010s.n4.02 Riassunto (Abstract)
    6Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma.Alinari L; Musuraca G; Tani M; Stefoni V; Gabriele A; Marchi E; Fina M; De Vivo A; Pileri S; Baccarani M; Zinzani PL2005LEUKEMIA & LYMPHOMA1.01 Articolo in rivista
    7Utility of baseline 18FDG PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphomaL. Ceriani;M. Martelli;P. L. Zinzani;A. J. M;B. Botto;C. Stelitano;M. Gotti;M. G. Cabras;L. Rigacci;L. Gargantini;F. Merli;G. Pinotti;D. Mannina;S. Luminari;A. Stathis;E. Russo;F. Cavalli;L. Giovanella;P. W. M;E. Zucca2015BLOOD1.01 Articolo in rivista
    8The unique biology and treatment of primary mediastinal B-cell lymphomaBroccoli, Alessandro; Zinzani, Pier Luigi2018BAILLIERE'S BEST PRACTICE IN CLINICAL HAEMATOLOGY1.01 Articolo in rivista
    9Understanding the group of peripheral T-cell lymphomas, unspecified.Zucca E.; Zinzani PL.2005CURRENT HEMATOLOGY REPORTS1.01 Articolo in rivista
    10The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patientsBroccoli, Alessandro; Casadei, Beatrice; Stefoni, Vittorio; Pellegrini, Cinzia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Marangon, Miriam; Argnani, Lisa; Zinzani, Pier Luigi2017BMC CANCER1.01 Articolo in rivista
    11Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendationsDreyling, Martin; Aurer, Igor; Cortelazzo, Sergio; Hermine, Olivier; Hess, Georg; Jerkeman, Mats; Le Gouill, Steven; Ribrag, Vincent; Trněný, Marek; Visco, Carlo; Walewski, Jan; Zaja, Francesco; Zinzani, Pier Luigi2018LEUKEMIA & LYMPHOMA1.01 Articolo in rivista
    12Tissue micro-array in haematopathology:present usage and potential.Pileri S.; Agostinelli C.; Campidelli C.; Righi S.; Piccioli M.; Bacci F.; Sabattini E.; Zinzani P.L.; Piccaluga P.P.2006HAEMATOLOGICA4.01 Contributo in Atti di convegno
    13Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani, P L; Bernengo MG; On behalf of the Gruppo Italiano Linfomi Cutanei (GILC).2012CANCER1.01 Articolo in rivista
    14Thoughts on the eradication of Helicobacter pylori infection in localized gastric mucosa-associated lymphoid tissue lymphoma.Zinzani PL.2006LEUKEMIA & LYMPHOMA1.01 Articolo in rivista
    15Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.B. Coiffier;M. Federico;D. Caballero;C. Dearden;F. Morschhauser;U. Jäger;L. Trümper;E. Zucca;M. G. da;R. Pettengell;E. Weidmann;F. d'Amore;H. Tilly;P. L. Zinzani2014CANCER TREATMENT REVIEWS1.01 Articolo in rivista
    16Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphomaDerenzini, Enrico; Iacobucci, Ilaria; Agostinelli, Claudio; Imbrogno, Enrica; Storlazzi, Clelia Tiziana; L`abbate, Alberto; Casadei, Beatrice; Ferrari, Anna; GHELLI LUSERNA DI RORÀ, Andrea; Martinelli, Giovanni; Pileri, Stefano; Zinzani, PIER LUIGI2015EXPERIMENTAL HEMATOLOGY & ONCOLOGY1.01 Articolo in rivista
    17The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.Luminari S;Biasoli I;Arcaini L;Versari A;Rusconi C;Merli F;Spina M;Ferreri AJ;Zinzani PL;Gallamini A;Mastronardi S;Boccomini C;Gaidano G;D'Arco AM;Di Raimondo F;Carella AM;Santoro A;Musto P;Federico M2013ANNALS OF ONCOLOGY1.01 Articolo in rivista
    18The Small Molecule CHK1/CHK2 Inhibitor PF-0477736 (Pfizer) Demonstrates Single Agent Activity and Synergizes with Chemotherapy in Diffuse Large B-Cell LymphomaDerenzini E; Iacobucci I; Brighenti E; Cattina F; Davis RE; Pileri S; Martinelli G; Baccarani M; Zinzani PL2011BLOOD4.02 Riassunto (Abstract)
    19The role of surgery for haematologic neoplasms of bone.Mavrogenis A.F.; Angelini A.; Pala E.; Zinzani P.; Ruggieri P.2012ACTA ORTHOPAEDICA BELGICA1.01 Articolo in rivista
    20The role of mitoxantrone in the treatment of indolent lymphomas.HAGEMEISTER F; CABANILLAS F; COLEMAN M; GREGORY SA; ZINZANI P.2005ONCOLOGY1.01 Articolo in rivista

    Dettaglio

    Nome completo:
    ZINZANI, PIER LUIGI
    Varianti:
    [Zinzani PL]
    P. ZINZANI
    ZINZANI P.L.
    ZINZANI P
    ZINZANI L
    P. L. Zinzani
     
     
     
    Powered by IRIS-about IRIS-Utilizzo dei cookie
    Logo CINECA  Copyright © 2019